This topic contains a solution. Click here to go to the answer

Author Question: Asthma is a respiratory disease in which _____. A) the mucous membrane of the trachea becomes ... (Read 25 times)

tth

  • Hero Member
  • *****
  • Posts: 579
Asthma is a respiratory disease in which _____.
 A) the mucous membrane of the trachea becomes inflamed
  B) an inflammatory response obstructs the airways
  C) the lungs become infected and filled with pus
  D) swallowing is difficult and painful

Question 2

Clients who have undergone surgery or have been on prolonged bed rest are at increased risk for _____.
 A) COPD
  B) bronchitis
  C) pulmonary embolism
  D) atelectasis



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Chocorrol77

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

B

Answer to Question 2

C




tth

  • Member
  • Posts: 579
Reply 2 on: Feb 27, 2019
Wow, this really help


gcook

  • Member
  • Posts: 343
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library